A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS). This is an ASCO Meeting Abstract from the 2014 ASCO ...

Detecting synovitis by clinical examination is difficult, even though clinical examination is currently the gold standard for diagnosing synovitis in rheumatic diseases -- especially rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . In patients with early psoriatic arthritis who are naïve to disease-modifying antirheumatic drugs, swollen ...

To address these issues, Le Boedec and colleagues performed simultaneous clinical joint examination and ultrasound to assess synovitis and evaluated the factors that were associated with concordance ...

Please provide your email address to receive an email when new articles are posted on . A 60-year-old woman presented to us with newly diagnosed breast cancer. She had a screening mammogram that ...

Subclinical synovitis is significantly more common among patients with psoriasis without musculoskeletal involvement than healthy controls, according to a review published online July 16 in JAMA ...

We herein describe three cases of pigmented villonodular synovitis with chondroid metaplasia. Two cases involved the temporomandibular joint, whereas the remaining one case occurred in the hip joint.

Unlike synovitis, the presence of joint effusions on MRI among patients with hand osteoarthritis (OA) was not associated with pain or progression, Dutch researchers reported. Pain in a specific joint ...

Advanced phase I/II evaluation of tumor-targeted gene delivery: Intravenous retrovector encoding mutant anticyclin G1 as stand-alone therapy for chemotherapy-resistant bone and soft tissue sarcoma.

Novartis’ interleukin-17A (IL-17A) Cosentyx (secukinumab) demonstrated early synovitis reduction in patients with active psoriatic arthritis in the phase IIIb ULTIMATE study. Synovitis, or joint ...